Year-end report 2025: New CEO takes the helm - initiates the next phase of Enzymatica's international expansion
PR Newswire —
LUND, Sweden, Feb. 18, 2026 /PRNewswire/ -- Fourth quarter January-December Net sales reached SEK 18.3 (17.2) million The operating result totaled SEK -10.2 (-13.7) million. Earnings per share, basic and diluted, were SEK -0.05 (-0.05). Cash flow from operating activities totaled SEK 0.5...